IL178690A - Receptor receptor agonists and peptides - Google Patents

Receptor receptor agonists and peptides

Info

Publication number
IL178690A
IL178690A IL178690A IL17869006A IL178690A IL 178690 A IL178690 A IL 178690A IL 178690 A IL178690 A IL 178690A IL 17869006 A IL17869006 A IL 17869006A IL 178690 A IL178690 A IL 178690A
Authority
IL
Israel
Prior art keywords
cys
compound according
gly
asn
artificial sequence
Prior art date
Application number
IL178690A
Other languages
English (en)
Hebrew (he)
Other versions
IL178690A0 (en
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of IL178690A0 publication Critical patent/IL178690A0/en
Publication of IL178690A publication Critical patent/IL178690A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/16—Oxytocins; Vasopressins; Related peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL178690A 2004-08-11 2006-10-17 Receptor receptor agonists and peptides IL178690A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04019029 2004-08-11
PCT/US2005/027772 WO2006020491A1 (en) 2004-08-11 2005-08-03 Peptidic vasopressin receptor agonists

Publications (2)

Publication Number Publication Date
IL178690A0 IL178690A0 (en) 2007-02-11
IL178690A true IL178690A (en) 2013-10-31

Family

ID=34926126

Family Applications (1)

Application Number Title Priority Date Filing Date
IL178690A IL178690A (en) 2004-08-11 2006-10-17 Receptor receptor agonists and peptides

Country Status (25)

Country Link
US (2) US8148319B2 (de)
EP (1) EP1776133B1 (de)
JP (1) JP4664363B2 (de)
KR (1) KR100884323B1 (de)
CN (1) CN1964732B (de)
AR (1) AR050914A1 (de)
AT (1) ATE509944T1 (de)
AU (1) AU2005274070B2 (de)
BR (1) BRPI0511466B8 (de)
CA (1) CA2567797C (de)
DK (1) DK1776133T3 (de)
ES (1) ES2366702T3 (de)
IL (1) IL178690A (de)
JO (1) JO2937B1 (de)
MX (1) MX2007001396A (de)
NO (1) NO342449B1 (de)
NZ (1) NZ550707A (de)
PL (1) PL1776133T3 (de)
PT (1) PT1776133E (de)
RU (1) RU2355701C2 (de)
SA (1) SA05260254B1 (de)
SI (1) SI1776133T1 (de)
TW (1) TWI364291B (de)
WO (1) WO2006020491A1 (de)
ZA (1) ZA200700772B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO2937B1 (en) * 2004-08-11 2016-03-15 فيرينغ.بي.في Tight muscles of the peptide vascular tensioner receptor
KR101194586B1 (ko) 2006-02-10 2012-10-25 훼링 비.브이. 신규 화합물
DK1984012T3 (en) * 2006-02-13 2016-03-29 Ferring Bv USE OF peptidic vasopressin receptor agonists
WO2009037586A2 (en) * 2007-08-14 2009-03-26 Ferring B.V. Use of peptidic vasopressin receptor agonists
KR101814186B1 (ko) 2008-09-17 2018-03-14 키아스마 인코포레이티드 약제학적 조성물 및 연관된 투여방법
JO3109B1 (ar) * 2012-05-10 2017-09-20 Ferring Bv منبهات لمستقبلات v1a
US9388214B2 (en) * 2014-11-05 2016-07-12 Ferring B.V. V1A receptor agonists
RU2634272C1 (ru) * 2016-08-10 2017-10-24 Закрытое акционерное общество "Санкт-Петербургский институт фармации" Композиция с дезамино-аргинин-вазотоцином для парентерального введения и способ её получения
IL313083A (en) 2016-10-21 2024-07-01 Amryt Endo Inc Terlipressin compositions and their methods of use
US11033601B2 (en) 2017-09-14 2021-06-15 The Regents Of The University Of Colorado, A Body Corporate Selective inhibition of V1b for treating fatty liver
CN109748950B (zh) * 2017-11-02 2020-10-30 深圳翰宇药业股份有限公司 一种固相合成血管升压素受体肽激动剂selepressin的方法
DK3517543T3 (da) 2018-01-30 2020-12-07 Bachem Ag Fremstilling af glucagonpeptider
JP2022507380A (ja) 2018-11-15 2022-01-18 フェリング ベスローテン フェンノートシャップ 敗血症を治療するための化合物、組成物及び方法
PH12023550152A1 (en) * 2020-07-17 2024-03-18 Pharmain Corp V1a receptor partial agonist and method of use
AU2023353572A1 (en) * 2022-09-30 2025-03-20 Ferring B.V. Mixed vasopressin receptor agonist-antagonist for modulating mean arterial pressure

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1076984A (en) 1963-04-05 1967-07-26 Sandoz Ltd Improvements in or relating to local anaesthetics containing orn-vasopressin
NL129421C (de) * 1963-08-30 1900-01-01
CS235151B1 (cs) 1982-08-26 1985-05-15 Michal Lebl Způsob dělení Dal isomerů analogů oxytocinu
US4829051A (en) 1983-04-05 1989-05-09 Vega Laboratories, Inc. N-substituted derivatives of 1-desaminovasopressin
US4483794A (en) * 1983-05-10 1984-11-20 Ceskoslovenska Akademie Ved Analogs of neurohypophysial hormones
CS242062B1 (cs) 1984-08-23 1986-04-17 Milan Zaoral Vasopresinová a vasotocinová analoga a způsob jejich přípravy
SE457055B (sv) 1986-08-18 1988-11-28 Ferring Ab Topisk straalskyddsgel foer mukosa innehaallande kaerlsammandragande substanser
SE469473B (sv) 1987-10-07 1993-07-12 Ferring Ab Vasoaktiva peptider
SE502644C2 (sv) * 1990-02-27 1995-11-27 Ferring Ab Vasoaktiva vasotocinderivat
RU2063979C1 (ru) 1992-02-24 1996-07-20 Всесоюзный научно-исследовательский институт технологии кровезаменителей и гормональных препаратов Пептиды последовательности окситоцина
US5516795A (en) * 1994-09-12 1996-05-14 Abbott Laboratories Heteroatom substituted propanyl derivatives having 5-lipoxygenase inhibitory activity
RU2073010C1 (ru) * 1994-10-26 1997-02-10 Российско-германское совместное предприятие "Константа" Способ синтеза лизин-вазопрессина в растворе
GB9617021D0 (en) 1996-08-13 1996-09-25 Salpep Biotechnology Inc Novel peptides for treatment of inflammation and shock
SE9701162D0 (sv) * 1997-03-27 1997-03-27 Karolinska Innovations Ab New use II
SE9701161D0 (sv) 1997-03-27 1997-03-27 Karolinska Innovations Ab New use I
WO1999013092A1 (en) 1997-09-11 1999-03-18 The Public Health Research Institute Of The City Of New York, Inc. Enhancement of mucosal antibody responses by interleukin-6
NZ506839A (en) 1998-03-09 2003-05-30 Zealand Pharma As Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
SE0001440D0 (sv) 2000-04-18 2000-04-18 Entretech Medical Ab A drug against climacteric disorders
US20030109670A1 (en) * 2001-02-09 2003-06-12 University Of Utah Research Foundation Cone snail peptides
WO2003082334A1 (fr) 2002-03-29 2003-10-09 Wakamoto Pharmaceutical Co.,Ltd. Medicaments pour augmenter la quantite de fluide lacrymal
US6861236B2 (en) * 2002-05-24 2005-03-01 Applied Nanosystems B.V. Export and modification of (poly)peptides in the lantibiotic way
ES2353690T3 (es) 2002-10-03 2011-03-04 Neuropharmacology Services, Llc Oxitocina para su uso en el tratamiento del autismo y del trastorno de asperger.
US7183255B2 (en) 2003-02-26 2007-02-27 Intradialytic Pharmaceuticals Method for stabilizing blood pressure in hemodialysis subjects
JO2937B1 (en) * 2004-08-11 2016-03-15 فيرينغ.بي.في Tight muscles of the peptide vascular tensioner receptor
KR101194586B1 (ko) * 2006-02-10 2012-10-25 훼링 비.브이. 신규 화합물
DK1984012T3 (en) * 2006-02-13 2016-03-29 Ferring Bv USE OF peptidic vasopressin receptor agonists
AU2007338899A1 (en) 2006-12-20 2008-07-03 Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. Nucleoside cyclic phosphoramidates for the treatment of RNA-dependent RNA viral infection
RU2342949C1 (ru) 2007-03-26 2009-01-10 Юрий Георгиевич Жуковский Применение [дезамино-1, изолейцин-3, аргинин-8]вазопрессина в качестве средства для увеличения выведения почкой солей натрия и усиления обратного избирательного всасывания из почечных канальцев в кровь воды-растворителя

Also Published As

Publication number Publication date
NO342449B1 (no) 2018-05-22
HK1100280A1 (en) 2007-09-14
US20120196808A1 (en) 2012-08-02
KR100884323B1 (ko) 2009-02-18
PL1776133T3 (pl) 2011-09-30
CN1964732B (zh) 2011-03-02
TWI364291B (en) 2012-05-21
WO2006020491A1 (en) 2006-02-23
JP4664363B2 (ja) 2011-04-06
EP1776133A4 (de) 2008-12-31
BRPI0511466B1 (pt) 2018-01-23
EP1776133A1 (de) 2007-04-25
RU2007101238A (ru) 2008-09-20
AR050914A1 (es) 2006-12-06
SA05260254B1 (ar) 2008-05-19
CN1964732A (zh) 2007-05-16
BRPI0511466B8 (pt) 2021-05-25
JO2937B1 (en) 2016-03-15
ATE509944T1 (de) 2011-06-15
US20090054309A1 (en) 2009-02-26
NZ550707A (en) 2010-07-30
SI1776133T1 (sl) 2011-07-29
DK1776133T3 (da) 2011-07-18
KR20070029183A (ko) 2007-03-13
RU2355701C2 (ru) 2009-05-20
PT1776133E (pt) 2011-09-02
BRPI0511466A (pt) 2007-12-26
CA2567797A1 (en) 2006-02-23
IL178690A0 (en) 2007-02-11
TW200612976A (en) 2006-05-01
ZA200700772B (en) 2008-09-25
CA2567797C (en) 2012-07-10
MX2007001396A (es) 2007-04-19
AU2005274070A1 (en) 2006-02-23
AU2005274070B2 (en) 2008-02-07
US8778881B2 (en) 2014-07-15
NO20071314L (no) 2007-05-10
US8148319B2 (en) 2012-04-03
ES2366702T3 (es) 2011-10-24
EP1776133B1 (de) 2011-05-18
JP2008509221A (ja) 2008-03-27

Similar Documents

Publication Publication Date Title
US8778881B2 (en) Peptidic vasopressin receptor agonists
JP2011516460A (ja) オキシトシン類似体
DK1984012T3 (en) USE OF peptidic vasopressin receptor agonists
CA2641959C (en) Novel compounds
HK1100280B (en) Peptidic vasopressin receptor agonists
EP0292273A2 (de) Vasopressin-Antagonisten
HK1117071B (en) Use of peptidic vasopressin receptor agonists
HK1116807B (en) Vasopressin v1a receptor agonists

Legal Events

Date Code Title Description
FF Patent granted
KB20 Patent renewed for 20 years